Recursion Pharmaceuticals Inc Earnings

The next earnings date for Recursion Pharmaceuticals Inc is August 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Recursion Pharmaceuticals Inc Earnings

Report DateEstimated Earnings Per Share
11/05/2025$-0.32
08/12/2025$-0.34

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Recursion Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/07/2025After Market$-0.503.10%
02/25/2025Before Market$-0.53-27.16%
11/06/2024After Market$-0.342.86%
08/08/2024Before Market$-0.400.00%
05/09/2024After Market$-0.397.14%
02/27/2024After Market$-0.426.67%
11/09/2023Before Market$-0.43-13.16%
08/08/2023Before Market$-0.38-2.70%
05/08/2023Before Market$-0.342.86%
02/27/2023After Market$-0.31-6.90%
11/08/2022After Market$-0.357.89%
08/09/2022After Market$-0.38-2.70%
05/10/2022After Market$-0.33-430.00%
03/23/2022Before Market$-0.38-22.58%
11/10/2021Before Market$-0.280.00%
08/13/2021Before Market$-0.31-34.78%
05/12/2021After Market$-1.33-461.89%
03/03/2021---$-0.25---

More About Recursion Pharmaceuticals Inc

Website
https://www.recursion.com
Country
USA
Full Time Employees
800

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

“Recursion Pharmaceuticals Inc Earnings” Can Refer to the Recursion Pharmaceuticals Inc Earnings Date

Some people say “Recursion Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Recursion Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Recursion Pharmaceuticals Inc Stock on the Earnings Date

If you own Recursion Pharmaceuticals Inc stock (RXRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Recursion Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Recursion Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Recursion Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Recursion Pharmaceuticals Inc earnings or anything else related to the stock market.